Introduction
High blood pressure (BP) is a major modifiable risk factor contributing to the current pandemic of cardiovascular diseases (CVD). This is particularly challenging for developing countries that are estimated to house three-fourths of the global burden of patients with hypertension in the coming few decades. 1 Despite the well-established benefits of lowering BP control and thorough existing guidelines, even in parts of the developed world less than one-third of the patients achieve recommended BP values of <140/90.
2
Projected increase in CVD is expected to be much greater in South Asia than in any other region worldwide, 3 where it is expected to more than double over the next 20 years. 4 The burden of coronary heart disease (CHD) in South Asians extends beyond regional concerns, as CHD mortality and morbidity remain higher in immigrant South Asians living in western regions compared with native western populations. 5 Data from the developing countries, particularly in Pakistan, are barely emerging in this regard. The Heart of the Matter doi:10.1093/eurheartj/suz065 its 14 regional chapters throughout Pakistan. More than 150 volunteers were selected to conduct this survey with the help of the pharmaceutical industry and were trained at PHL regional chapters. All of the 14 sites' team members were supervised by the regional chapter coordinators. Screening camps were arranged in the month of May 2017 by the PHL at public places, hospital visiting areas, and at various institutions, to allow the general public to be screened for their BP's. After taking informed consent, research volunteers at every camp enrolled individuals aged 18 or above. An MMM pre-piloted data tool was used to record the demographic data including age and gender. Blood pressures of every individual were recorded in the sitting position, using an OMRON digital BP apparatus. Hypertension was defined according to the JNC7 guidelines. 6 A subject was classified as having hypertension if the BP reading was 140/90 mmHg or in those taking medication for high BP. Study participants' identities were kept anonymous and their privacy was ensured. All data were coded and analysed by the MMM statistics team. Mean 6 1 standard deviation (SD) were computed for all continuous data, and frequencies were calculated for categorical variables.
Results
General characteristics of study participants are presented in Table 1 . There were 5333 participants screened in this study. Of these, 3536 were males (66.3%) and 1757 were females (33.0%). The mean age of study participants was 45.0 (SD 11.6) years. Age and gender standardized mean systolic BP (SBP) was 133.2 mmHg and diastolic BP was 84.8 mmHg ( Table 2) . A total of 55.2% (2943/5333) participants had hypertension. This survey shows the very high prevalence of hypertension in this Pakistani population.
Discussion
Results of this survey show a high proportion (55.2%) of our study group had hypertension with a mean age of 45.0 years. The incidence of cardiovascular complications are rising sharply in this region therefore control of BP is extremely important in the Pakistani population. 7, 8 In 2014-15, Pakistan Health Research Council conducted a survey on Non-Communicable Risk Factors in Pakistan, which shows about 45.3% people never got their BP checked, almost 37% of the population had Stage I hypertension and 15.9% had Stage II hypertension. 9 Modifiable risk factors of CVD such as hypercholesterolaemia and sedentary life style also need to be evaluated as they are associated with high BP. Studies have shown that increased cholesterol levels alter the peripheral and the renal vascular tone increasing the progression of high-normal BP to hypertension (BP > 140/>90). 10 Similarly, physical inactivity raises the SBP, while elevating total cholesterol levels as well. 11, 12 In Pakistan, with a population of 197 million, it is very important to develop more effective strategies for better high BP detection and management to achieve adequate therapeutic control of BP. It will include national education campaigns to increase the awareness about high BP, controlling modifiable risk factors, better patient counselling to improve lifestyle, and adherence to treatment. Also large scale studies at a national level are needed to evaluate the association of BP with modifiable risk factors in the Pakistani population. This will help in the development of better and effective strategies to prevent and treat hypertension in the Pakistani population and reduce the increasing burden of CVD in this region. 
